D. Western Therapeutics Institute (TSE:4576) Ending Cash Position: 円0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
39 GF Score
Price 円88.00
GF Value 円44.59
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Ending Cash Position?

D. Western Therapeutics Institute TSE:4576 -1.12% 39 Ending Cash Position is 円0.0 Mil as of Jun. 2026. GuruFocus rates TSE:4576 with a GF Score™ of 39/100 and a GF Value™ of 円44.59 (Significantly Overvalued). The stock has 4 warning signs investors should review.

D. Western Therapeutics Institute's Ending Cash Position for the quarter that ended in Jun. 2026 was 円0.0 Mil.

D. Western Therapeutics Institute's annual Ending Cash Position declined from Dec. 2023 (円1,867.3 Mil) to Dec. 2024 (円1,126.0 Mil) but then increased from Dec. 2024 (円1,126.0 Mil) to Dec. 2025 (円1,709.8 Mil).

D. Western Therapeutics Institute Ending Cash Position Related Terms

D. Western Therapeutics Institute Ending Cash Position Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Ending Cash Position Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,933.74 2,334.67 1,867.26 1,126.04 1,709.79

D. Western Therapeutics Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4576
39GF Score
D. Western Therapeutics Institute Inc TSE:4576
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

D. Western Therapeutics Institute's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1126.034+583.756
=1,709.8

D. Western Therapeutics Institute's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of 円0.0 Mil mean?
D. Western Therapeutics Institute (TSE:4576) has a Ending Cash Position of 円0.0 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Ending Cash Position too high?
D. Western Therapeutics Institute's current Ending Cash Position is 円0.0 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Ending Cash Position compare to VRTX and REGN?
D. Western Therapeutics Institute's Ending Cash Position of 円0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Ending Cash Position is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Significantly Overvalued. The stock's GF Value™ is 円44.59, compared to a current price of 円88.00 — trading 97.4% above its estimated fair value. The current Ending Cash Position is 円0.0 Mil. D. Western Therapeutics Institute's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Ending Cash Position is 円0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円88.00 is trading 97.4% above its estimated GF Value™ of 円44.59. GuruFocus considers D. Western Therapeutics Institute to be Significantly Overvalued.

Key valuation signals for TSE:4576:

  • Ending Cash Position: 円0.0 Mil
  • GF Value™: 円44.59 vs. price of 円88.00 (97.4% above fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
39GF Score

Get the complete analysis for TSE:4576

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円88.00
Price
円44.59
GF Value